Clinical trial
Gene Methylation and Estradiol Levels in Random FNA Samples as Biomarkers for Breast Cancer Risk
NCT00896636 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gene Methylation and Estradiol Levels in Random FNA Samples as Biomarkers for Breast Cancer Risk
- Lead sponsor
- Northwestern University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 20, 2009
- Completion date
- January 31, 2022
- Enrollment
- 385 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, healthy, no evidence of disease